Enzybel

What Enzybel does

Enzybel is a Belgian affiliate brand operating under Natix sa (Waterloo, Belgium), producing plant- and animal-derived bioactive ingredients — specifically a range of "out-of-nature" enzymes, 100% pure essential oils, and snail extract — for sale to industrial customers. The company serves five primary verticals: pharmaceutical manufacturers (high-purity enzymes and bioactive compounds produced under strict GMP standards, including applications in enzyme replacement therapies for pancreatic insufficiency, anti-inflammatory solutions, wound care, and digestive health), food & beverage manufacturers (enzymes and botanical extracts that transform proteins, optimize gluten functionality, enhance taste, and improve clarity), nutraceutical manufacturers (bioactive ingredients with targeted health benefits), cosmetics and personal care brands (enzymes, snail extract, and botanical actives for skin regeneration, hydration, and anti-aging), and feed & pet food manufacturers (enzymes and bioactives that enhance digestibility and nutrient absorption).

The company's underlying technology is biochemical rather than digital: it harvests and refines natural bioactive compounds from plant and animal sources, with proprietary positioning in extraction know-how and in specialized inputs such as snail extract, which it markets as the "gold standard" in regenerative skincare. Its closest peers within the same Natix umbrella include PT Bromelain Enzyme (Southeast Asia), Terhormon (European pharma-grade pancreatin, majority-stake acquired in 2025), ENZYMCO, and Virunga Enzymes (Africa), giving the Enzybel commercial brand access to a multi-region network for both sourcing and distribution.

Commercially, Enzybel runs a B2B enterprise direct-sales model aimed at qualified professionals, manufacturers, institutions, and organizations operating under applicable regulatory frameworks. Products are sold as one-time industrial ingredient purchases incorporated into customer formulations, with no publicly disclosed pricing. Go-to-market is built around the corporate website, content/news marketing, and participation in flagship industry events such as CPHI Milan and FIE Frankfurt. As an affiliate brand within a larger multi-affiliate group rather than a standalone quoted entity, Enzybel has no disclosed revenue, funding rounds, or financial metrics.

Name

Enzybel

Legal name

Natix sa

Website

https://enzybel.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Enzybel produces plant- and animal-derived enzymes, essential oils, and snail extract for B2B customers across pharmaceutical, food & beverage, nutraceutical, cosmetics, and feed & pet food manufacturing, operating as an affiliate brand of Natix sa.

Ownership category

akta.pro rank

Product category

Specialty ingredients and bioactive compounds

NAICS

Medicinal and Botanical Manufacturing (325411), Pesticide and Other Agricultural Chemical Manufacturing (325320)

SIC

Medicinal Chemicals & Botanical Products (2833), Biological Products, (No Disgnostic Substances) (2836), Agricultural Chemicals (2870)

akta.pro primary industry

Enzymes (Phytase, Xylanase, Protease) (AFADALAD)

akta.pro secondary industries

Protein Processing Enzymes (Meat/Seafood/Plant) (AFAJAIAF), Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM), Phytogenics & Botanicals (Essential Oils, Plant Extracts) (AFADAKAF)

Keywords

• Plant-derived enzymes
• Natural bioactive ingredients
• Pharmaceutical-grade enzymes
• Essential oils supply
• Snail extract cosmetics

Headquarters

HQ city

Waterloo

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Bioactive Ingredients B2B Sales: Revenue generated from selling natural enzyme products, bioactive compounds, essential oils, and snail extract to pharmaceutical, food & beverage, nutraceuticals, cosmetics, and feed & pet food manufacturers. Products are sold as ingredients for incorporation into customer formulations, typically through long-term supply relationships with qualified manufacturers and institutions operating under applicable regulatory frameworks.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Enzybel harvests and refines natural bioactive compounds from plant and animal sources, producing out-of-nature enzymes, essential oils, and snail extract for industrial manufacturers. The company supplies pharmaceutical-grade enzymes for enzyme replacement therapies, food processing enzymes for clean-label applications, and bioactive ingredients for cosmetics, nutraceuticals, and animal feed. As an affiliate brand under Natix sa, Enzybel serves qualified professionals, manufacturers, institutions, and organizations operating under applicable regulatory frameworks.

Product overview

Enzybel is an affiliate brand of Natix operating within a multi-brand portfolio. The core product portfolio consists of out-of-nature enzymes (plant and animal-derived), essential oils, and snail extract. Enzybel specifically focuses on pharmaceutical-grade applications within the Natix ecosystem, providing high-purity enzymes and bioactive compounds. The products serve diverse sectors including pharma, food & beverage, nutraceuticals, cosmetics, and feed & pet food. Additional affiliate brands under Natix include PT Bromelain Enzyme, TERHORMON, ENZYMCO, and Virunga Enzymes.

Differentiator

Problem solved

Functional benefit

Products and services

• Out-of-nature enzymes Range of plant and animal-derived enzymes used as ingredients for pharmaceutical, food & beverage, nutraceutical, cosmetics, and feed applications. Innovative natural enzymes tailored to industry needs, including pharmaceutical-grade enzymes for enzyme replacement therapies.
• Essential oils 100% pure essential oils providing naturally powerful bioactive properties for cosmetics, nutraceuticals, and food & beverage applications.
• Snail extract Premium snail extract positioned as the gold standard in regenerative skincare, used in cosmetics and personal care formulations for skin regeneration, hydration, and anti-aging benefits.

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core and supporting.

• TerhormoncoreStrategic or Co-development PartnerNatix acquired majority stake in Terhormon, marking a significant expansion in European pharma-grade pancreatin production. This strategic acquisition strengthens Natix/Enzybel's position in the pharmaceutical enzyme market, particularly for pancreatic enzyme replacement therapies.
• PT Bromelain EnzymecoreStrategic or Co-development PartnerAffiliate partner specializing in bromelain enzyme production, part of the Natix group's Southeast Asian operations. Contributes to the company's diversified enzyme portfolio and global supply chain.
• ENZYMCOsupportingStrategic or Co-development PartnerAffiliate company within the Natix network, contributing to the overall enzyme and bioactive compound production capabilities.
• Virunga EnzymessupportingStrategic or Co-development PartnerAffiliate partner based in Africa, expanding the Natix group's geographic footprint and sourcing capabilities for natural enzyme production.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Lonza: Global contract development and manufacturing organization with significant biologicals and pharma-grade production capabilities. Comparable to Enzybel in pharmaceutical-grade enzyme production and biological ingredients.
• Symrise: Global supplier of cosmetic actives, flavors, and nutrition ingredients with a substantial naturals and bioactives portfolio. Comparable to Enzybel in cosmetics, essential oils, and bioactive ingredient supply.
• International Flavors & Fragrances (IFF): Global ingredients major with enzyme, cultures, and bioactive offerings across food, beverage, and personal care. Comparable to Enzybel in food processing enzymes and cosmetic bioactives as part of a much wider portfolio.
• DSM-Firmenich: Global nutrition, health, and beauty ingredients major with a broad enzyme and bioactive portfolio serving food, feed, pharma, and personal care. Comparable to Enzybel across end markets but operates at vastly greater scale with a wider product portfolio.
• Kerry Group: Global taste and nutrition ingredients company serving food, beverage, and pharma markets. Comparable to Enzybel in food/beverage and nutraceutical applications with overlapping clean-label positioning.
• BASF: Global chemical major with a significant agricultural solutions and nutrition & care division including feed enzymes and bioactive ingredients. Comparable to Enzybel in feed and agricultural applications but with much broader chemical portfolio.

Direct peers

• Novonesis: Global leader in enzyme solutions and bioscience ingredients formed by the merger of Novozymes and Chr. Hansen. Directly comparable to Enzybel as a major supplier of industrial, food, and health-related enzymes across multiple verticals.
• Amano Enzyme: Specialist enzyme manufacturer producing industrial, food, and diagnostic enzymes from natural and microbial sources. Closely comparable to Enzybel as a focused enzyme supplier serving multiple industrial verticals.
• AB Enzymes: Specialist enzyme manufacturer for food, beverage, and industrial applications, part of ABF Ingredients. Direct peer to Enzybel in food-grade enzyme solutions with similar customer base of food and beverage manufacturers.

Regional players

• Ingredion: Major ingredient supplier specializing in plant-based ingredients and sweeteners for food and beverage. Comparable to Enzybel's food & beverage segment through overlapping clean-label, nature-derived ingredient offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Enzybel